Who is Monal
Monal Therapeutics is a development stage biotechnology company dedicated to transforming oncology with innovative solutions based on cutting-edge science. Monal has created targeted drug complexes specifically aimed at the key PROTEIN in cancer cells – Cytochrome-C, the engine of the apoptosis reaction.
Monal’s bioengineered, intelligent, non-toxic drug complexes target cancer at its core by disrupting dysfunctional mitochondrial dynamics, halting cancer growth, preventing metastasis, and enhancing the patient’s immune response.
Leadership and Researchers
We currently have a team of international researchers committed to providing effective and dignified treatment for cancer patients.
Contact Us
We are always seeking collaborations in areas outside our portfolio focus, such as metabolic disorders, and pain management where the partner brings deep expertise in a specific field and can help guide the choice of sensor and therapeutic. Please reach out if you have an idea
